BillionToOne Debuts Publicly, Aiming to Revolutionize Genetic Testing
BillionToOne's Public Offering: A New Era in Genetic TestingOn November 6, 2025, BillionToOne, a trailblazer in the genetic testing industry, took a significant leap by going public. This IPO not only
This IPO could lead to increased investments in biotech, making genetic testing more accessible and widespread.
